ITRM920281A0 - Perfezionata composizione biologica in particelle e procedimento per la sua produzione - Google Patents

Perfezionata composizione biologica in particelle e procedimento per la sua produzione

Info

Publication number
ITRM920281A0
ITRM920281A0 IT92RM281A ITRM920281A ITRM920281A0 IT RM920281 A0 ITRM920281 A0 IT RM920281A0 IT 92RM281 A IT92RM281 A IT 92RM281A IT RM920281 A ITRM920281 A IT RM920281A IT RM920281 A0 ITRM920281 A0 IT RM920281A0
Authority
IT
Italy
Prior art keywords
particles
procedure
production
improved biological
biological composition
Prior art date
Application number
IT92RM281A
Other languages
English (en)
Inventor
Peter Gassmann
Heinz Sucker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27202407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM920281(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ITRM920281A0 publication Critical patent/ITRM920281A0/it
Publication of ITRM920281A1 publication Critical patent/ITRM920281A1/it
Application granted granted Critical
Publication of IT1254323B publication Critical patent/IT1254323B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
ITRM920281A 1991-04-19 1992-04-16 Perfezionata composizione biologica in particelle e procedimento per la sua produzione IT1254323B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4112854 1991-04-19
DE4113016 1991-04-20
DE4113343 1991-04-24

Publications (3)

Publication Number Publication Date
ITRM920281A0 true ITRM920281A0 (it) 1992-04-16
ITRM920281A1 ITRM920281A1 (it) 1993-10-16
IT1254323B IT1254323B (it) 1995-09-14

Family

ID=27202407

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920281A IT1254323B (it) 1991-04-19 1992-04-16 Perfezionata composizione biologica in particelle e procedimento per la sua produzione

Country Status (16)

Country Link
EP (1) EP0580690B2 (it)
JP (1) JP3695754B2 (it)
AT (1) AT410896B (it)
AU (1) AU1577992A (it)
CA (1) CA2108018C (it)
DE (1) DE4291156T1 (it)
ES (1) ES2069995T5 (it)
FR (1) FR2675382B1 (it)
GB (1) GB2269536B (it)
IE (1) IE921230A1 (it)
IL (1) IL101635A0 (it)
IT (1) IT1254323B (it)
MX (1) MX9201782A (it)
NO (1) NO933695D0 (it)
WO (1) WO1992018105A1 (it)
ZA (1) ZA922834B (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
EP2283821A1 (en) * 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
TW497974B (en) * 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US6337092B1 (en) 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances
ATE318132T1 (de) 1998-03-30 2006-03-15 Jagotec Ag Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
DE19821951A1 (de) * 1998-05-15 1999-11-18 Basf Ag Cyclosporin-Zubereitungen
KR100635456B1 (ko) 1998-05-29 2006-10-18 스키에파마 캐나다 인코포레이티드 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
IL143197A0 (en) 1998-11-20 2002-04-21 Rtp Pharma Inc Dispersible phospholipid stabilized microparticles
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US7008644B2 (en) * 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7858609B2 (en) 2005-11-28 2010-12-28 Marinus Pharmaceuticals Solid ganaxolone formulations and methods for the making and use thereof
EP2099420B8 (en) 2006-11-17 2017-03-15 PharmaSol GmbH Nanocrystals for use in topical cosmetic formulations and method of production thereof
BRPI0717721A2 (pt) 2006-11-28 2013-10-29 Marinus Pharmaceuticals "partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
HU230862B1 (hu) 2008-04-28 2018-10-29 DARHOLDING Vagyonkezelő Kft Berendezés és eljárás nanorészecskék folyamatos üzemű előállítására
GB201410869D0 (en) * 2014-06-18 2014-07-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MX392636B (es) 2014-10-31 2025-03-24 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
AU2016338672A1 (en) 2015-10-16 2018-04-12 Marinus Pharmaceuticals, Inc. Injectable neurosteroid formulations containing nanoparticles
EP3481387A4 (en) 2016-08-11 2020-04-08 Ovid Therapeutics Inc METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES
US10391105B2 (en) 2016-09-09 2019-08-27 Marinus Pharmaceuticals Inc. Methods of treating certain depressive disorders and delirium tremens
US11266662B2 (en) 2018-12-07 2022-03-08 Marinus Pharmaceuticals, Inc. Ganaxolone for use in prophylaxis and treatment of postpartum depression
JP7754799B2 (ja) 2019-08-05 2025-10-15 マリナス ファーマシューティカルズ， インコーポレイテッド てんかん重積状態の治療に使用するためのガナキソロン
WO2021113834A1 (en) 2019-12-06 2021-06-10 Marinus Pharmaceuticals, Inc. Ganaxolone for use in treating tuberous sclerosis complex
JP7804312B2 (ja) * 2020-08-07 2026-01-22 国立大学法人信州大学 リポソームおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532993A (en) * 1975-03-07 1978-11-22 Beecham Group Ltd Injectable antibiotic compositions
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US5002940A (en) * 1984-11-06 1991-03-26 Ciba-Geigy Corporation Solid drug formulations and stable suspensions
CH673395A5 (it) * 1987-01-30 1990-03-15 Ciba Geigy Ag
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
US4963362A (en) † 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
CH679277A5 (it) † 1989-02-09 1992-01-31 Sandoz Ag

Also Published As

Publication number Publication date
ZA922834B (en) 1993-10-18
ES2069995T5 (es) 2000-11-16
JPH06506926A (ja) 1994-08-04
IT1254323B (it) 1995-09-14
GB2269536A (en) 1994-02-16
AU1577992A (en) 1992-11-17
CA2108018C (en) 2003-04-15
CA2108018A1 (en) 1992-10-20
FR2675382B1 (fr) 1995-05-12
MX9201782A (es) 1992-10-01
WO1992018105A1 (en) 1992-10-29
FR2675382A1 (fr) 1992-10-23
GB2269536B (en) 1995-05-10
AT410896B (de) 2003-08-25
ATA901092A (de) 2003-01-15
EP0580690B2 (en) 2000-09-13
ITRM920281A1 (it) 1993-10-16
DE4291156T1 (de) 1994-10-20
GB9319585D0 (en) 1993-12-15
JP3695754B2 (ja) 2005-09-14
IE921230A1 (en) 1992-10-21
IL101635A0 (en) 1992-12-30
NO933695D0 (no) 1993-10-14
EP0580690A1 (en) 1994-02-02
EP0580690B1 (en) 1995-03-15
ES2069995T3 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
ITRM920281A0 (it) Perfezionata composizione biologica in particelle e procedimento per la sua produzione
IT8548445A0 (it) Composizione farmaceutica e lento rilascio e metodo per la sua preparazione
FI883583L (fi) Polymeeripartikkelit ja niiden valmistaminen
HU9802116D0 (en) 19-nor-d-vitamin compounds with biologically effect and pharmaceutical compositions containing them
ITMI920737A1 (it) Vitamina e polietossilata e metodo per la sua preparazione
IT1231945B (it) Materiale in particelle contenente biossido di titanio e procedimento per la sua preparazione
AU7286887A (en) Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
BR8902306A (pt) Composicao e processo para sua preparacao
DE68927586D1 (de) Cermet und dessen Herstellungsverfahren
HU911811D0 (en) Process for the production of acylized alpha, omega-amino-alcoholic derivatives and for using them in pesticide substances
EP0435199A3 (en) Acrylic gel material and acrylic gel preparation
FI920356A7 (fi) Biologinen valmiste ja sen käyttö
GB8919726D0 (en) Ws7338 substances and preparation thereof
BR8801757A (pt) Composicao em particulas
IT1208416B (it) Preparato di sucralfato e procedimento per la sua produzione
IT9021728A0 (it) L-carnitina deidrogenasi e procedimento per la sua produzione
IT9020067A0 (it) Conglomerato per edilizia rurale e stradale e procedimento per la sua preparazione
IT1238207B (it) Preparato vitaminizzato contenente l'enzima lisozima impiegabile in zootecnica e procedimento per la sua produzione.
BR8904964A (pt) Composicao em particulas utilizavel no amaciamento de tecidos e processo para sua preparacao
SG48827A1 (en) Modified biological material
IT1247726B (it) Composizione acaricida e procedimento per la sua produzione.
GB8918370D0 (en) Material for use in biological cryoprotection
GB2227402B (en) Improvements in or relating to gemstones
FI901958A7 (fi) Resiiniä estäviä dipeptidejä, menetelmä niiden valmistamiseksi, niitä sisältäviä aineita ja niiden käyttö